Given the anti-inflammatory and insulin sensitizing effects of n-3 PUFA, RCTs in these higher risk women are therefore needed to evaluate the role of n-3 PUFA in preventing intrauterine growth restriction and macrosomia. The gene discussed is INS; the disease is fetal growth restriction.